|
A Case-Based Review on Venous Thromboembolic Events in Malignant Hematology |
04/14/2025 - 4:00pm to 5:00pm EDT |
|
A Fascinating Case |
10/29/2025 - 4:00pm to 4:30pm EDT |
|
A Long and Winding Road: Treatment of Relapsed/Refractory CLL after BTK and BCL2 Inhibitors |
02/24/2025 - 4:00pm to 5:00pm EST |
|
Acute Promyelocytic Leukemia, Torsades de Pointes,Artificial Intelligence, And the Oncologist |
09/10/2025 - 4:00pm to 4:30pm EDT |
|
Allogeneic HSCT for MDS or AML with mutated TP53: Who? How? When? If? |
01/27/2025 - 4:00pm to 5:00pm EST |
|
ASCT or CAR T as Consolidation in Newly Diagnosed Multiple Myeloma |
04/28/2025 - 4:00pm to 5:00pm EDT |
|
Bispecific Antibodies for Myeloma in 2025 |
11/19/2025 - 4:00pm to 4:30pm EST |
|
Curing Sickle Cell Disease and Transfusion Dependent Thalassemia: Let’s count the ways |
08/27/2025 - 4:00pm to 4:30pm EDT |
|
Cytopenias After CAR T-Cell Therapy for Relapsed and Refractory Multiple Myeloma at Duke |
09/24/2025 - 4:00pm to 4:30pm EDT |
|
Cytopenias Following CAR-T Cell Therapy |
05/19/2025 - 4:00pm to 5:00pm EDT |
Facebook
X
LinkedIn
Forward